MedTrace Logo

Mobile Apps Enhancing Acupressure Therapy Compliance and Efficacy for Asthenopia

NCT06418191 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2025-03-04

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a mobile application works to improve adherence to acupressure therapy in asthenopia. It will also learn about the efficacy of acupressure as a therapy for asthenopia. The main questions it aims to answer are:

-Does a mobile application have a role to improve therapy compliance and efficacy of self-guided acupressure in asthenopia?

Researchers will compare users of a mobile app to non-users of a mobile app to see if a mobile app works to improve adherence to acupressure therapy in asthenopia

Participants will:

* Do acupressure 2 times every day for 4 weeks
* Filling in the absence link has been after doing acupressure every day
* Fill out the link regarding the condition of asthenopia once per week

Conditions

  • Asthenopia

Interventions

PROCEDURE

Acupressure

Acupressure is a technique that involves applying pressure to specific points on the body. It is based on the same principles as acupuncture but uses pressure from fingers, palms, elbows, or specialized devices instead of needles.

Sponsors & Collaborators

  • Indonesia University

    lead OTHER

Principal Investigators

  • KEPK FKUI-RSCM · The Ethics Committee of the Faculty of Medicine, University of Indonesia - RSCM

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2024-08-01
Completion
2024-09-01

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06418191 on ClinicalTrials.gov